MiNK Therapeutics (INKT) stock: insider trades, news & valuation
Net sellingShare price and insider trades
MiNK Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $47K of INKT stock on the open market.
Get emailed when insiders cluster-buy stocks like INKT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
INKT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $19K | 2 |
| Q1 2026 | — | 0 | $27K | 6 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 MiNK Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $47K. 0 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 5SEC | Barbara RyanDirector | Sell | 1,00021,969 held (−4%) | $12.80 | $13K | -16.2% | — |
| Jun 5SEC | Barbara RyanDirector | Sell | 50022,969 held (−2%) | $12.68 | $6K | -15.5% | — |
| Mar 11SEC | Barbara RyanDirector | Sell | 50020,906 held (−2%) | $15.57 | $8K | -31.1% | — |
| Mar 11SEC | Barbara RyanDirector | Sell | 50020,406 held (−2%) | $15.30 | $8K | -29.9% | — |
| Mar 11SEC | Barbara RyanDirector | Sell | 30021,406 held (−1%) | $15.28 | $5K | -29.8% | — |
| Mar 11SEC | Barbara RyanDirector | Sell | 20021,706 held (−1%) | $10.17 | $2K | +5.4% | — |
| Mar 4SEC | Barbara RyanDirector | Sell | 40022,006 held (−2%) | $10.86 | $4K | -1.3% | — |
| Mar 4SEC | Barbara RyanDirector | Sell | 10021,906 held (−0%) | $10.83 | $1K | -1.0% | — |
Insiders at MiNK Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Barbara RyanDirector | — | $47K | Jun 5, 2026 | — |
INKT stock: common questions
Are MiNK Therapeutics, Inc. insiders buying INKT stock?
In the past 12 months, 0 insiders reported open-market purchases of INKT worth $0.
Are MiNK Therapeutics, Inc. insiders selling INKT stock?
1 insiders reported sales worth $47K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is INKT's 52-week range?
Over the past year INKT has traded between $8.56 and $14.97. It last closed at $10.72 on Oct 9, 2026.